CIMG (NASDAQ:IMG), a business group specializing in digital health and technology-driven sales development, announced its financial results for the first quarter ended December 31, 2025.
The period was marked by a dramatic scaling of the company’s new business lines in the Asia market and a strategic commitment to digital assets as a core component of its treasury.
Total revenue for the first quarter surged to $15,768,796, a substantial increase from the $22,853 reported in the prior-year period.
This growth reflects the initial commercial impact of the company’s expansion into medicine-food homology products and its newly launched computing power solutions.
Specifically, the company generated significant contract revenue from enterprise customers, including China Merchants Bank, for its GPU hardware devices integrated with AI data processing modules.
CIMG’s balance sheet is increasingly defined by its digital asset strategy.
As of December 31, 2025, the company held 730 Bitcoins with a carrying value of approximately $63,978,821.
Based on the shares outstanding at quarter-end, the company reported a book value per share of approximately $3.6.
While the Bitcoin holdings provide significant asset backing, the company recorded a net loss for the period, largely due to non-cash fair value variations in the cryptocurrency’s market price.
Operationally, CIMG accelerated its footprint in China by establishing wholly-owned subsidiaries in Shenzhen and Foshan.
The company also completed the acquisition of Braincon HK and its Beijing-based subsidiary, Beijing Xin Miao Shi Dai Technology, to strengthen its localized R&D and production capabilities for the computing power industry.